NCT00079352View on ClinicalTrials.gov

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

Given IV

DRUG

gemcitabine hydrochloride

Given IV

DRUG

irinotecan hydrochloride

Given IV

Trial Locations (1)

87106

University of New Mexico, Albuquerque

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00079352 - Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter